Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Function-Friendly Semi-Fowler Positioning for Coronary Angiography and PCI

12 novembre 2026 mis à jour par: Shanghai Zhongshan Hospital

Pilot Study on the Feasibility and Safety of Function-Friendly Semi-Fowler Positioning in Coronary Angiography and Percutaneous Coronary Intervention

This study will assess whether planned coronary angiography (CAG), and simple percutaneous coronary intervention (PCI) when needed, can be completed safely and technically while participants are in a semi-sitting position with the head of the procedure table raised to 60 degrees. Ten clinically stable adults scheduled for an elective procedure are planned. The first stage will include participants undergoing CAG. After a safety review, the study may include participants expected to need only simple PCI. Heart rhythm, blood pressure, and blood oxygen will be monitored continuously. If predefined safety criteria occur, staff will lower the table or return the participant to a flat position and provide usual clinical care. Researchers will describe procedure completion, image quality, radiation exposure, contrast use, tolerance of the position, and safety events through 3 days after the procedure. This exploratory study is not designed to establish treatment efficacy.

Aperçu de l'étude

Statut

Pas encore de recrutement

Les conditions

Description détaillée

This is a prospective, single-center, open-label, single-arm, staged early-feasibility study at Zhongshan Hospital, Fudan University. The planned enrollment is 10 participants aged 18 to 75 years. Eligible participants are clinically stable and scheduled for elective transradial CAG or planned simple PCI, and can tolerate a monitored 60-degree semi-Fowler position for at least 10 minutes before the procedure. The first stage prioritizes CAG. Participants expected to need only simple PCI may be enrolled only after a safety review confirms that the workflow is executable without unacceptable risk. During CAG and, when clinically indicated, simple PCI, the procedure table will be raised to a default head elevation of 60 degrees. ECG, blood pressure, and oxygen saturation will be monitored continuously. If chest pain, significant dyspnea, persistent oxygen saturation below 90%, systolic blood pressure below 90 mmHg or a decrease of at least 30% requiring intervention, sustained ventricular tachycardia or fibrillation, cerebral hypoperfusion, equipment collision, catheter or tubing traction, or another predefined safety concern occurs, the positioning intervention will stop and the table will be lowered or the participant returned to 0-degree supine; usual clinical care will take priority. CAG and PCI technical success will be described among participants undergoing the respective procedure. Safety events will be collected from the start of the positioning intervention through 3 days after the procedure. Other measures include image quality, completion of standard projections, fluoroscopy time, dose-area product, contrast volume, procedure duration, positioning changes, and tolerance. No investigational drug is used. The commercial angiography X-ray system is used as a carrier for the positioning intervention; the study does not modify or evaluate the device.

Type d'étude

Interventionnel

Inscription (Estimé)

10

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

      • Shanghai, Chine
        • Zhongshan Hospital, Fudan University
        • Contact:

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 75 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  1. Age 18 to 75 years.
  2. Clinically stable and scheduled for elective coronary angiography (CAG) or planned simple percutaneous coronary intervention (PCI), with no ongoing resting ischemia.
  3. Meets clinical indications for coronary angiography or intervention, with ischemic evidence consistent with coronary artery disease based on symptoms, ECG, or noninvasive imaging.
  4. Planned radial access; the operator expects the procedure can be performed using standard catheters and devices.
  5. Able to tolerate a monitored 60-degree semi-Fowler position for at least 10 minutes before the procedure.
  6. Body size, weight, shoulder width, and range of motion are within equipment and support-system limits, and the participant can be secured using the manufacturer-approved fixation system.
  7. Able to understand the study and provide written informed consent.

Exclusion Criteria:

  1. Pregnant or breastfeeding, or the participant or spouse plans pregnancy within the next 6 months.
  2. Known contraindication to local anesthetic or history of severe contrast-media allergy.
  3. Neurologic or psychiatric disease or language impairment that prevents effective communication or cooperation.
  4. Serious comorbidity with expected survival less than 6 months.
  5. Uncontrolled hypertension (screening systolic blood pressure >180 mmHg or diastolic blood pressure >100 mmHg) or baseline systolic blood pressure <100 mmHg.
  6. Acute coronary syndrome, ongoing ischemia, hemodynamic instability, cardiogenic shock, or need for emergency CAG/PCI.
  7. Decompensated heart failure, left ventricular ejection fraction <30%, inability to maintain oxygenation at rest, or estimated glomerular filtration rate <30 mL/min/1.73 m^2.
  8. Known or highly suspected high-risk left main disease, chronic total occlusion, complex bifurcation disease, severe calcification, or other anatomy expected to require complex PCI.
  9. Platelet count <50 × 10^9/L or coagulation results outside the institution usual acceptable range.
  10. Participation in another clinical trial or research study within 2 months before screening.
  11. Back pain, stiffness, limited mobility, or injury preventing tolerance of transition from supine to the study position.
  12. Inability to secure the torso reliably, inability to complete the pre-procedure positioning-tolerance test, or investigator judgment that emergency return to supine may be restricted.
  13. Any other condition for which the investigator considers participation unsafe.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Autre
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Function-Friendly Semi-Fowler Positioning

All participants receive the same positioning intervention during elective transradial CAG and, if clinically indicated, simple PCI. The procedure table is raised to a default head elevation of 60 degrees, with continuous ECG, blood pressure, and oxygen saturation monitoring. If predefined safety concerns occur, the table angle is lowered or the participant is returned to 0-degree supine and usual clinical care is provided.

The procedure table head is elevated to a default 60-degree semi-Fowler position during elective transradial coronary angiography and, if clinically indicated, simple PCI. ECG, blood pressure, and oxygen saturation are continuously monitored. If predefined safety criteria occur, the table angle is reduced or the participant is immediately returned to 0-degree supine and usual clinical care is provided. The commercial angiography X-ray system and adjustable procedure table are used as available clinical equipment; no device hardware, software, collision protection, interlocks, image processing, or dose-control functions are modified or evaluated.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Proportion of Participants With Coronary Angiography (CAG) Technical Success
Délai: During the CAG procedure

The number of participants undergoing CAG who complete the planned CAG in the prespecified semi-Fowler position without position-related unplanned return to supine or substantial angle reduction, procedure discontinuation, access-site change, missing key projections, or participant/equipment collision, and whose images are independently confirmed to be diagnostic, divided by the number of participants undergoing CAG.

During the CAG procedure
Proportion of Participants With Percutaneous Coronary Intervention (PCI) Technical Success
Délai: During the PCI procedure

Among participants who undergo PCI, the proportion who complete planned device delivery, treatment, and withdrawal while meeting the protocol-defined positioning and safety requirements. PCI success is calculated using participants who undergo PCI as the denominator.

During the PCI procedure
Participants With Position-Related Serious Adverse Events or Prespecified Safety Events
Délai: From the start of the positioning intervention through 3 days after the procedure

Number and proportion of participants experiencing a position-related serious adverse event or any prespecified safety event: hemodynamic instability, hypoxia, sustained arrhythmia, cerebral hypoperfusion, unplanned respiratory or circulatory support, mechanical collision, or emergency return to supine.

From the start of the positioning intervention through 3 days after the procedure

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Diagnostic Acceptability of Coronary Angiography Images
Délai: During the procedure

Coronary angiography and fluoroscopy image quality rated on a 1-to-3 Likert scale; a score of 2 or 3 is acceptable. Images are assessed by two independent physicians, with adjudication by a third if needed.

During the procedure
Completion of Standard Coronary Angiographic Views and Visualization of Major Coronary Segments
Délai: During the procedure

Completion of standard left anterior oblique, right anterior oblique, cranial, and caudal projections, and the ability to visualize the left anterior descending, left circumflex, and right coronary arteries and their major branches.

During the procedure
Total Fluoroscopy Time
Délai: During the procedure

Total fluoroscopy time recorded during the CAG and, if performed, PCI procedure.

During the procedure
Dose-Area Product (DAP)
Délai: During the procedure

Dose-area product and other radiation dose parameters recorded by the angiography system.

During the procedure
Contrast Volume
Délai: During the procedure

Total contrast-media volume administered during the procedure.

During the procedure
Procedure Duration
Délai: During the procedure

Total duration of the CAG procedure and, if performed, PCI procedure, recorded as specified in the study CRF.

During the procedure
Positioning Tolerance and Adjustments
Délai: During the procedure

Table-head angle, number and reasons for position adjustments, participant symptoms, unplanned return to 0-degree supine, and equipment collision events.

During the procedure
Access and Device Delivery Completion
Délai: During the procedure

Successful radial artery access and completion of planned device delivery and withdrawal, as applicable to the procedure performed.

During the procedure

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Junbo Ge, Fudan University

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

25 novembre 2026

Achèvement primaire (Estimé)

1 mai 2028

Achèvement de l'étude (Estimé)

1 novembre 2028

Dates d'inscription aux études

Première soumission

12 novembre 2026

Première soumission répondant aux critères de contrôle qualité

12 novembre 2026

Première publication (Réel)

18 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

12 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

INDÉCIS

Description du régime IPD

The protocol states that any data sharing must use de-identified data and receive the required approvals. Whether individual participant data will be shared, and the timing, access process, and supporting information, have not yet been determined.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner